-+ 0.00%
-+ 0.00%
-+ 0.00%

GMO Payment Gateway (TSE:3769) Stock Price Faces Valuation Scrutiny After Margin Strength

Simply Wall St·08/16/2026 23:34:31
Listen to the news

GMO Payment Gateway stock closed Q3 earnings day at ¥10,150, with the recent 90 day climb of about 15.7% meeting a set of numbers that look steady rather than explosive. The market has been paying up for growth; however, the real story today sits in profitability. Basic earnings per share for the quarter came in at ¥91.37 and trailing twelve month net profit margin stood at 27.6%. The question now is whether that kind of earnings power still justifies a P/E multiple well above the broader Japanese diversified financials sector.

Is GMO Payment Gateway still priced for growth or already discounting more than current earnings justify? See how the current 30.6x P/E compares with cash flows, growth forecasts and peer multiples in the valuation analysis for GMO Payment Gateway

Q3 2026 Earnings Summary

  • Revenue (Q3 2026 vs. Q3 2025): ¥23,644 million vs. ¥20,245.182 million (up about 16.8%)
  • Net Income (Excl. Extra Items, Q3 2026 vs. Q3 2025): ¥6,939 million vs. ¥5,738.499 million (up about 20.9%)
  • Basic EPS (Q3 2026 vs. Q3 2025): ¥91.37 vs. ¥75.65 (up about 20.7%)
  • Net Profit Margin, Trailing 12 Months (Q3 2026 vs. prior year): 27.6% vs. 24.9% (margin higher year over year)

Prefer clear charts instead of another wall of earnings tables and ratios? Get a full visual view of GMO Payment Gateway, with an at a glance focus on its valuation picture, in the company report for GMO Payment Gateway.

TSE:3769 Trailing 12-Month Earnings & Revenue History as at Aug 2026
TSE:3769 Trailing 12-Month Earnings & Revenue History as at Aug 2026

GMO Payment Gateway results backing growth narrative

The latest quarter gives supporters of GMO Payment Gateway some tangible backing. Revenue and net income both move higher year on year, and basic EPS rises from ¥75.65 to ¥91.37. Profitability looks firm with a trailing 12 month net margin of 27.6%, higher than the prior year. That picture lines up with the idea of a payment infrastructure business that is scaling well. The recent ¥10b unsecured bond issue also points to access to funding that can support expansion in core digital payment and fintech services.

Short term risks and bearish arguments in context

Bears often worry that fintech growth stories can hide pressure on profitability or balance sheet strain. GMO Payment Gateway’s latest numbers point the other way in the short run. Margins are higher than a year ago and earnings per share are moving up, which does not obviously flag immediate stress. The recent bond issue increases financial obligations, so cautious investors may watch how that capital is deployed. For now, the combination of rising income and access to medium term funding softens some of the more immediate downside concerns.

Access what the street is quietly baking into its multi year scenarios for GMO Payment Gateway and see where the consensus might break from the current ¥10,150 share price with the analyst estimates for GMO Payment Gateway.

Stay Ahead With Simply Wall St

If the latest earnings strength and 30.6x P/E keep GMO Payment Gateway on your radar, register for free with Simply Wall St and add it to a Watchlist to track share price against fair value and watch for a better entry point. Once you own it, use the Portfolio Command Center to cut through market noise and focus on the key valuation and earnings updates that matter for your holdings. For a longer term view, tap into crowd insights and different angles on GMO Payment Gateway through the Community. By surfacing potential catalysts and risks early, Simply Wall St helps you move faster and stay ahead of the market.

Seeking Alternatives Beyond GMO Payment Gateway?

Fresh stock ideas can move from quiet buildup to breakout momentum fast. Use these under the radar lists before the best entry ranges get caught by the crowd and act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.